83 FR 55730 - National Heart, Lung, and Blood Institute; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 216 (November 7, 2018)

Page Range		55730-55730
FR Document		2018-24294

Federal Register, Volume 83 Issue 216 (Wednesday, November 7, 2018)

[Federal Register Volume 83, Number 216 (Wednesday, November 7, 2018)]
[Notices]
[Page 55730]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-24294]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Primate Center for Gene Therapy.
    Date: November 30, 2018.
    Time: 2:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6701 Rockledge Drive, Room 
7180, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Tony L Creazzo, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA National Heart, Lung, and 
Blood Institute, National Institutes of Health, 6701 Rockledge 
Drive, Room 7180, Bethesda, MD 20892-7924, 301-827-7913.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: November 1, 2018.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-24294 Filed 11-6-18; 8:45 am]
 BILLING CODE 4140-01-P

55730 Federal Register / Vol. 83, No. 216 / Wednesday, November 7, 2018 / Notices

Biorepository—from studies funded by data archived in NICHD DASH without • Monitor data submissions, data
NICHD. The potential for public benefit creating an account. Users who wish to requests and biospecimen requests
to be achieved through sharing study submit or request research data and/or • Notify interested recipients of updates
data and/or biospecimen inventories for biospecimen inventories must register to data and biospecimen inventories
secondary analysis is significant. NICHD for an account. stored in NICHD DASH
DASH supports NICHD’s mission to Information will be collected from
ensure that every person is born healthy • Help NICHD understand the use of
those wishing to create an account,
and wanted, that women suffer no NICHD DASH study data and
sufficient to identify them as unique
harmful effects from reproductive Users. Those submitting or requesting biospecimen inventories by the
processes, and that all children have the data and/or biospecimen inventories research community
chance to achieve their full potential for will be required to provide additional All the data collected from use of
healthy and productive lives, free from supporting information to ensure proper
disease or disability, and to ensure the NICHD DASH except for information
use and security of NICHD DASH study provided in the annual progress reports
health, productivity, independence, and data and biospecimen inventories. The
well-being of all people through optimal are for the purposes of internal
information collected is limited to the administrative management of NICHD
rehabilitation. Study data and essential data required to ensure the
biospecimen sharing and reuse will DASH. Information gathered through
management of Users in NICHD DASH the annual progress reports may be used
promote testing of new hypotheses from is efficient and the sharing of data and
data already collected, facilitate in publications describing performance
biospecimens among investigators is
transdisciplinary collaboration, of the DASH system.
effective. The primary uses of the
accelerate scientific findings and enable OMB approval is requested for 3
information collected from Users by
NICHD to maximize the return on its years. There are no costs to respondents
NICHD will be to:
investments in research. other than their time. The total
Anyone can access NICHD DASH to • Communicate with the Users with estimated annualized burden hours are
browse and view descriptive regards to their data submission, data
204.
information about the studies and study requests and biospecimen requests

ESTIMATED ANNUALIZED BURDEN HOURS
Number of Average time
Number of responses Total annual
Form per response
respondents per burden hour
(in hours)
respondent

User Registration ............................................................................................. 200 1 5/60 17
Data Submission and Biospecimen Inventory Submissions ........................... 36 1 2 72
Data Request ................................................................................................... 60 1 1 60
Biospecimen Request ...................................................................................... 36 1 1 36
Data Use Annual Progress Report .................................................................. 60 1 10/60 10
Biospecimen Use Annual Progress Report ..................................................... 36 1 10/60 6
Institutional Certification Template .................................................................. 36 1 5/60 3

Total .......................................................................................................... 200 200 ........................ 204

Dated: November 1, 2018. as amended. The contract proposals and (Catalogue of Federal Domestic Assistance
Jennifer M. Guimond, the discussions could disclose Program Nos. 93.233, National Center for
Project Clearance Liaison, Eunice Kennedy confidential trade secrets or commercial Sleep Disorders Research; 93.837, Heart and
Shriver National Institute of Child Health and property such as patentable material, Vascular Diseases Research; 93.838, Lung
Human Development, National Institutes of and personal information concerning Diseases Research; 93.839, Blood Diseases
Health. individuals associated with the contract and Resources Research, National Institutes
[FR Doc. 2018–24313 Filed 11–6–18; 8:45 am] proposals, the disclosure of which of Health, HHS)
BILLING CODE 4140–01–P would constitute a clearly unwarranted Dated: November 1, 2018.
invasion of personal privacy. Ronald J. Livingston, Jr.,
DEPARTMENT OF HEALTH AND Name of Committee: National Heart, Lung, Program Analyst, Office of Federal Advisory
HUMAN SERVICES and Blood Institute Special Emphasis Panel; Committee Policy.
Primate Center for Gene Therapy. [FR Doc. 2018–24294 Filed 11–6–18; 8:45 am]
National Institutes of Health Date: November 30, 2018. BILLING CODE 4140–01–P
Time: 2:00 p.m. to 4:00 p.m.
National Heart, Lung, and Blood Agenda: To review and evaluate contract
Institute; Notice of Closed Meeting proposals.
Place: National Institutes of Health, 6701
Pursuant to section 10(d) of the Rockledge Drive, Room 7180, Bethesda, MD
amozie on DSK3GDR082PROD with NOTICES1

Federal Advisory Committee Act, as 20892 (Telephone Conference Call).
amended, notice is hereby given of the Contact Person: Tony L Creazzo, Ph.D.,
following meeting. Scientific Review Officer, Office of Scientific
The meeting will be closed to the Review/DERA National Heart, Lung, and
public in accordance with the Blood Institute, National Institutes of Health,
provisions set forth in sections 6701 Rockledge Drive, Room 7180, Bethesda,
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., MD 20892–7924, 301–827–7913.

VerDate Sep<11>2014 17:46 Nov 06, 2018 Jkt 247001 PO 00000 Frm 00043 Fmt 4703 Sfmt 9990 E:\FR\FM\07NON1.SGM 07NON1

Document Created: 2018-11-07 00:05:14
Document Modified: 2018-11-07 00:05:14

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		November 30, 2018.
FR Citation		83 FR 55730

83 FR 55730 - National Heart, Lung, and Blood Institute; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 216 (November 7, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health